You have 9 free searches left this month | for more free features.

Early Stage Lung Cancer

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC Trial in Shanghai (Carbon ion beam radiotherapy)

Recruiting
  • Non-small Cell Lung Cancer
  • Carbon ion beam radiotherapy
  • Shanghai, Shanghai, China
    Shanghai Proton and Heavy Ion Center
Nov 10, 2022

Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC

Completed
  • Small Cell Lung Cancer
  • atezolizumab
  • Chalon-sur-Saône, France
  • +1 more
Jan 5, 2023

NSCLC Trial in Hamilton (indocyanine green)

Recruiting
  • Non-small Cell Lung Cancer
  • indocyanine green
  • Hamilton, Ontario, Canada
    St. Joseph's Healthcare Hamilton
May 11, 2021

Lung Cancer Trial in Indianapolis (Stereotactic Ablative Body Radiation (SABR))

Terminated
  • Lung Cancer
  • Stereotactic Ablative Body Radiation (SABR)
  • Indianapolis, Indiana
  • +2 more
Jul 22, 2022

NSCLC Trial in Philadelphia (device, drug, other)

Not yet recruiting
  • NSCLC
  • Aliya Pulsed Electric Fields (PEF) ablation
  • +3 more
  • Philadelphia, Pennsylvania
    Temple University
Oct 24, 2022

Lung Cancer, Nonsmall Cell, Stage IIIA, Lung Cancer Non-Small Cell Stage IIIB, Lung Cancer Non-Small Cell Stage III Trial in

Not yet recruiting
  • Lung Cancer, Nonsmall Cell, Stage IIIA
  • +4 more
  • E-health ecosystem of stepped psychosocial care
  • Usual psychosocial care
  • L'Hospitalet De Llobregat, Catalunya, Spain
    Institut Català d'Oncologia
Aug 9, 2022

NSCLC, NSCLC Stage I, NSCLC Stage II Trial in Stanford (AVENIO ctDNA Surveillance Kit, Durvalumab)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Stanford, California
    Stanford University
Mar 25, 2022

NSCLC Trial (Cardiac biomarkers, Echocardiography,Cardiac magnetic resonance imaging)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Cardiac biomarkers, Echocardiography,Cardiac magnetic resonance imaging
  • (no location specified)
Feb 19, 2022

NSCLC Metastatic Trial in Shanghai (Oba01)

Not yet recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Shanghai, China
    Department of Oncology, Shanghai Lung Cancer Center, Shanghai Ch
Oct 9, 2023

Sarcopenia and Nutritional Status in Early-stage Non-small Cell

Not yet recruiting
  • Sarcopenia
  • +2 more
  • Inbody 570
  • +2 more
  • Shanghai, Shanghai, China
    Huadong hospital, Fudan University
Jan 27, 2022

Lung Cancer Trial in United States (cytology specimen collection procedure, immunoenzyme technique, study of high risk factors)

Completed
  • Lung Cancer
  • cytology specimen collection procedure
  • +2 more
  • Tampa, Florida
  • +4 more
Jun 8, 2022

Lung Cancer Trial in Copenhagen (visicoil gold marker 0.7 x 20 mm)

Completed
  • Lung Cancer
  • visicoil gold marker 0.7 x 20 mm
  • Copenhagen, Denmark
    Department of Radiation Oncology, Rigshospitalet
Feb 23, 2021

RW Effectiveness of Lurbinectedin in Extensive Stage SCLC

Completed
  • Small-cell Lung Cancer
  • Paris, France
  • +1 more
Jan 5, 2023

Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma Trial in Palo Alto (biological, other, radiation)

Completed
  • Stage IA Non-Small Cell Lung Carcinoma
  • Stage IB Non-Small Cell Lung Carcinoma
  • Fresolimumab
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
Feb 2, 2022

Non-small-cell Lung Cancer Trial (Functional Imaging of Treatment Effects)

Completed
  • Non-small-cell Lung Cancer
  • Functional Imaging of Treatment Effects
  • (no location specified)
Jan 28, 2022

Lung Cancer Trial in Amsterdam (stereotactic radiotherapy, primary surgery)

Terminated
  • Lung Cancer
  • stereotactic radiotherapy
  • primary surgery
  • Amsterdam, Netherlands
    VU University Medical Center
Mar 16, 2022

Early-detection Based on Liquid Biopsy in Lung Cancer

Recruiting
  • Lung Cancer
    • Beijing, Beijing, China
      Peking University People's Hospital
    Mar 24, 2021

    NSCLC Stage I Trial in São Paulo (nivolumab)

    Recruiting
    • Non-small Cell Lung Cancer Stage I
    • nivolumab
    • São Paulo, Brazil
      Hospital Israelita Albert Einstein
    Sep 30, 2021

    NSCLC Trial in Porto (Durvalumab, standard of care RT/RCT)

    Recruiting
    • Non-small Cell Lung Cancer
    • Porto, Portugal
      Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto)
    Feb 23, 2022

    NSCLC Trial in Burlington (cis-diamminedichloroplatinum)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Burlington, Vermont
      University of Vermont
    May 20, 2022

    Lung Cancer Stage I, Lung Cancer Stage II, Lung Metastases Trial in Amsterdam, Leiden (Cardiac condition measurements)

    Recruiting
    • Lung Cancer Stage I
    • +2 more
    • Cardiac condition measurements
    • Amsterdam, Netherlands
    • +2 more
    Jul 9, 2021

    Lung Tumors, Surgery Trial in Nanjing (Segmentectomy, Lobectomy)

    Recruiting
    • Lung Neoplasms
    • Surgery
    • Segmentectomy
    • Lobectomy
    • Nanjing, Jiangsu, China
      Jiangsu Province Hospital, The First Affiliated Hospital of Nanj
    Apr 2, 2022

    NSCLC Trial in Kansas City (Non-ablative SBRT)

    Recruiting
    • Non-small Cell Lung Cancer
    • Non-ablative SBRT
    • Kansas City, Kansas
      University of Kansas Medical Center
    Mar 21, 2022

    Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in San Francisco (drug,

    Withdrawn
    • Lung Non-Small Cell Carcinoma
    • +9 more
    • San Francisco, California
      University of California, San Francisco
    Feb 17, 2022

    Stage II-III NSCLC Trial in Shanghai (4cycles(Toripalimab IV 240mg + platinum-based doublet chemo)+13 cycles(Toripalimab IV

    Recruiting
    • Stage II-III Non-small Cell Lung Cancer
    • 4cycles(Toripalimab IV 240mg + platinum-based doublet chemotherapy)+13 cycles(Toripalimab IV 240mg); Biological: Toripalimab
    • 4cycles(Placebo + platinum-based doublet chemotherapy)+13 cycles(Placebo )
    • Shanghai, China
      Shanghai Chest Hospital
    Apr 12, 2022